Vicarious Surgical Inc. Files 8-K on Officer/Director Changes
Ticker: RBOTW · Form: 8-K · Filed: Sep 16, 2025 · CIK: 1812173
| Field | Detail |
|---|---|
| Company | Vicarious Surgical Inc. (RBOTW) |
| Form Type | 8-K |
| Filed Date | Sep 16, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, corporate-governance, filing
Related Tickers: RBOT
TL;DR
Vicarious Surgical Inc. (RBOT) filed an 8-K on 9/16 detailing leadership changes effective 9/12.
AI Summary
Vicarious Surgical Inc. filed an 8-K on September 16, 2025, reporting changes effective September 12, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Specific details regarding the individuals involved and the nature of these changes were not provided in the excerpt.
Why It Matters
This filing indicates potential shifts in the leadership and governance of Vicarious Surgical Inc., which could impact the company's strategic direction and operational management.
Risk Assessment
Risk Level: medium — Changes in key officers or directors can signal internal shifts or strategic realignments that may carry inherent risks.
Key Numbers
- 0.0001 — Par Value (Class Common Stock Par Value Per Share)
- 11.50 — Exercise Price (Warrants to Purchase One Share of Class Common Stock)
Key Players & Entities
- Vicarious Surgical Inc. (company) — Registrant
- 0001812173 (company) — Central Index Key
- 001-39384 (company) — SEC File Number
- September 12, 2025 (date) — Date of earliest event reported
- September 16, 2025 (date) — Date of Report
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and roles are not detailed in the provided excerpt.
What is the effective date of the reported changes?
The earliest event reported is dated September 12, 2025.
What is the primary business of Vicarious Surgical Inc. according to the filing?
Vicarious Surgical Inc. is classified under 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES' with SIC code 3842.
What is the par value of Vicarious Surgical Inc.'s common stock?
The par value of Vicarious Surgical Inc.'s Class Common Stock is $0.0001 per share.
What is the exercise price for the company's warrants?
The exercise price for the warrants to purchase one share of Class Common Stock is $11.50 per share.
Filing Stats: 466 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2025-09-16 16:30:27
Key Financial Figures
- $0.0001 — tered Class A common stock, par value $0.0001 per share RBOT The New York Stock E
- $11.50 — mon stock, each at an exercise price of $11.50 per share RBOT WS The New York Stoc
Filing Documents
- ea0257572-8k_vicarious.htm (8-K) — 27KB
- 0001213900-25-088203.txt ( ) — 233KB
- rbot-20250912.xsd (EX-101.SCH) — 4KB
- rbot-20250912_def.xml (EX-101.DEF) — 26KB
- rbot-20250912_lab.xml (EX-101.LAB) — 36KB
- rbot-20250912_pre.xml (EX-101.PRE) — 25KB
- ea0257572-8k_vicarious_htm.xml (XML) — 6KB
02 Departure of Directors or Certain
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 12, 2025 (the "Effective Date"), Donald Tang resigned as a member of the Board of Directors (the "Board") of Vicarious Surgical Inc. (the "Company"), effective as of the Effective Date. Mr. Tang's resignation did not result from any disagreement regarding the Company's operations, policies or practices. In connection with Mr. Tang's resignation, the Board appointed Victoria Carr-Brendel as a member of the Audit Committee of the Board. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VICARIOUS SURGICAL INC. By: /s/ Stephen From Name: Stephen From Title: Chief Executive Officer Date: September 16, 2025 2